These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9577694)

  • 1. [The role of dynamic observation in the prevention of recurrences of stone formation].
    Dzeranov NK; Darenkov AF; Konstantinova OV; Beshliev DA; Borisik VI; Golovanov SA; Drozhzheva VV
    Urol Nefrol (Mosk); 1998; (2):12-4. PubMed ID: 9577694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of biochemical methods in follow-up and treatment of patients with urolithiasis].
    Dzeranov NK; Konstantinova OV; Beshliev DA; Golovanov SA; Drozhzheva VV
    Urologiia; 2001; (1):18-20. PubMed ID: 11233224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The most important factor for active urinary stone formation in patients with urolithiasis].
    Simić-Ogrizović S; Dopsaj V; Jovicić S; Milenković D; Jovanović D; Nesić V
    Med Pregl; 2007; 60 Suppl 2():117-20. PubMed ID: 18928175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of urinary excretion of magnesium in patients with urolithiasis with special respect to recurrence rate of stone formation (author's transl)].
    Zechner O; Latal D
    Urologe A; 1978 Jul; 17(4):258-60. PubMed ID: 684999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A metabolic approach to patients with calculi].
    Wildschutz T; Ekane S; Simon J; Schulman CC
    Acta Urol Belg; 1997 Oct; 65(3):9-14. PubMed ID: 9471888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric urolithiasis--evaluation of risk factors in 95 children.
    Erbagci A; Erbagci AB; Yilmaz M; Yagci F; Tarakcioglu M; Yurtseven C; Koyluoglu O; Sarica K
    Scand J Urol Nephrol; 2003; 37(2):129-33. PubMed ID: 12745721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local factors compared with systemic factors in the formation of bladder uric acid stones.
    Li WM; Chou YH; Li CC; Liu CC; Huang SP; Wu WJ; Huang CH
    Urol Int; 2009; 82(1):48-52. PubMed ID: 19172097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of cystine urolithiasis by a combination of extracorporeal shock wave lithotripsy and chemolysis.
    Ahlstrand C; Tiselius HG
    J Stone Dis; 1993 Jan; 5(1):32-8. PubMed ID: 10148259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recurrence-free and recurrent urolithiasis: metabolic differences].
    Konstantinova OV; Ianenko EK; Dzeranov NK
    Urologiia; 1999; (5):8-9. PubMed ID: 11150160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of phytotherapy in pre- and postoperative period in patients with urolithiasis].
    Dzeranov NK; Konstantinova OV; Moskalenko SA; Beshliev DA; Butin PS; Drozhzheva VV; Kon'kova TA
    Urologiia; 2005; (2):18-20. PubMed ID: 15989020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrograde ureteropyeloscopic treatment of 2 cm. or greater upper urinary tract and minor Staghorn calculi.
    Grasso M; Conlin M; Bagley D
    J Urol; 1998 Aug; 160(2):346-51. PubMed ID: 9679874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Personal experience in the diagnosis and monitoring of therapy in metabolic disorders with risk of crystallization in patients with recurrent urolithiasis].
    Stejskal D; Bártek J; Hrebícek J; Bána J; Zát'ura F; Mohapl P; Terber R
    Vnitr Lek; 1997 Dec; 43(12):781-6. PubMed ID: 9601889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of stone disease.
    Porena M; Guiggi P; Micheli C
    Urol Int; 2007; 79 Suppl 1():37-46. PubMed ID: 17726351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracorporeal shockwave lithotripsy in infants.
    Ramakrishnan PA; Medhat M; Al-Bulushi YH; Nair P; Al-Kindy A
    Can J Urol; 2007 Oct; 14(5):3684-91. PubMed ID: 17949522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Age of onset of urolithiasis: relation to clinical and metabolic risk factors].
    Lancina Martín JA; Novás Castro S; Rodríguez-Rivera García J; Ruibal Moldes M; Blanco Díez A; Fernández Rosado E; Barbagelata López A; González Martín M
    Arch Esp Urol; 2004 Mar; 57(2):119-25. PubMed ID: 15074780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary metabolic evaluations in solitary and recurrent stone forming children.
    DeFoor W; Minevich E; Jackson E; Reddy P; Clark C; Sheldon C; Asplin J
    J Urol; 2008 Jun; 179(6):2369-72. PubMed ID: 18433777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for biochemical abnormalities in urolithiasis patients.
    Orakzai N; Hanbury DC; Farrington K
    J Ayub Med Coll Abbottabad; 2004; 16(2):60-3. PubMed ID: 15455621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic evaluation and medical management of upper urinary tract stone disease. Guidelines from the Scandinavian Cooperative Group for Urinary Stones.
    Osther PJ; Grenabo L; Haraldsson G; Holmberg G; Lindell O; Mogensen P; Schultz A; Ulvik NM
    Scand J Urol Nephrol; 1999 Dec; 33(6):372-81. PubMed ID: 10636576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of agregatometry in diagnosis of urolithiasis].
    Kadyrov ZA; Istratov VG; Suleĭmanov SI; Ramishvili VSh
    Urologiia; 2007; (1):36-40. PubMed ID: 17471996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hounsfield unit density accurately predicts ESWL success.
    Magnuson WJ; Tomera KM; Lance RS
    Alaska Med; 2005; 47(2):6-9. PubMed ID: 16459477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.